When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?
Prediction markets currently give a 74% probability that When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA?. This contract trades at 74¢ on Kalshi, closing April 1, 2027. This market shows extreme illiquidity with zero volume and open interest despite a 350-day time horizon, suggesting minimal trader interest in Intellia's lonvo-z BLA submission timeline.
Analysis
This market shows extreme illiquidity with zero volume and open interest despite a 350-day time horizon, suggesting minimal trader interest in Intellia's lonvo-z BLA submission timeline. The Yes contract trading at 0¢ implies near-zero probability, yet the 58.7% implied yield on a Yes resolution and notably high 185.7% yield on No indicates significant mispricing or uncertainty that the market structure itself cannot resolve. The recent 3-cent price movement (61¢ to 64¢) on zero volume appears anomalous and warrants caution about order book depth before entering any position.
Resolution rules
If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Indicators
Regime
Trade
sf trade KXNEWDRUGAPPNTLA-LONV-27APR01 yes 100